The US Artificial Intelligence (AI) in Medical Imaging market size was valued at $630 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 33.4% from 2022 to 2030 and will reach $6318 Mn. The market is segmented by AI technology, solution, modality, application, and end user. The US Artificial Intelligence (AI) in the Medical Imaging market will grow due to Increasing demand for remote radiology services. Some of the key players in this market are Microsoft (US), NVIDIA (US), IBM (US), Intel Corporation (US), Google, Inc. (Subsidiary of Alphabet, Inc) (US), GE Healthcare (US), Digital Diagnostics, Inc (US), Xilinx (US), InformAI LLC (US), HeartFlow, Inc (US), Enlitic, Inc (US), Day Zero Diagnostics, Inc(US), Butterfly Network, Inc. (US), and others
The US Artificial Intelligence (AI) in Medical Imaging market size was valued at $630 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 33.4% from 2022 to 2030 and will reach $ 6318. Healthcare spending accounted for 17.7% of the US GDP, totaling $3.8 trillion. Medical imaging is a significant contributor to healthcare spending, with imaging tests accounting for a substantial portion of medical expenses. The use of AI in medical imaging has the potential to improve the efficiency and accuracy of imaging tests, leading to cost savings and improved patient outcomes. For example, AI algorithms can be used to detect abnormalities in medical images more accurately and efficiently than human radiologists, which can reduce the need for follow-up tests and imaging.
Additionally, AI-based solutions can help healthcare providers to develop personalized treatment plans for patients, which can improve outcomes and reduce healthcare costs in the long term. For example, AI algorithms can analyze medical imaging data and predict how patients will respond to different treatments, allowing providers to develop treatment plans that are tailored to each patient's individual needs.
The use of AI in medical diagnostics is growing quickly as a result of factors such as growing government initiatives to promote the use of AI-based technologies, increasing adoption of AI solutions by radiologists to relieve work pressure, the influx of big data, the availability of funding for AI-based startups, and the rise in cross-industry partnerships and collaborations. However, issues like a lack of skilled AI workers, hazy regulations, and a resistance among medical experts to accept these solutions are projected to hinder market growth.
The true goals during the development of AI technologies were to make them human-aware, or to create models with human-like thinking traits. Yet, the development of interactive and scalable AI computers continues to be difficult. However, the increase in human interference with AI approaches and interest in learning more about machine learning have created new research obstacles, such as those related to interpretation and presentation, issues with automated components, and intelligent crowdsourcing control. Interpretation difficulties include difficulties AI systems have comprehending precise instructions and knowledge from humans. Delivering the output and feedback methods of the AI system are among the presentation obstacles. Consequently, the greatest opportunity for AI engineers is to create human-aware AI systems.
In 2021, North America accounted for the largest market share. However, the Asia Pacific market is projected to register the highest CAGR of 42.6% during the forecast period. The high growth rate of the Asia Pacific market can primarily be attributed to the growth strategies adopted by key players in emerging markets, the digitization of medical diagnostics infrastructure, the rising geriatric population, the rise in the prevalence of cancer, and the implementation of favorable government initiatives. The use of AI in medical imaging has the potential to impact healthcare expenditure in the US in the future. Hence the market will grow during the forecast period across the nation.
Market Growth Drivers
The application of artificial intelligence (AI) to medical imaging is one of the most promising health and medical innovation areas. AI is used in medical imaging in many ways, such as picture collection, processing for assisted reporting, scheduling follow-up visits, data storage, data mining, and more. In recent years, AI has shown outstanding sensitivity and precision in classifying imaging abnormalities, and it is certain to improve tissue-based detection and characterization. Machine learning (ML), a subfield of artificial intelligence, makes use of computational models and methods that resemble the organic neural networks of the brain. The structure of neural networks is composed of layers of connected nodes. Each network node weighs and summarises the input data before being sent to the activation function.
The application of AI in healthcare and medical imaging altered the diagnostic process, which fueled the expansion of the market for AI in medical imaging on a global scale. Artificial intelligence aids medical professionals in the execution of the picture acquisition process as well as in the analysis of these images for the diagnosis and individualized treatment of each patient. Researchers have used AI to automatically recognize challenging patterns in imaging data and objectively assess radiographic features. Artificial intelligence has been applied in radiation oncology to improve a variety of unique picture modalities that are used at different phases of the therapy. Radiation omics, which comprises the high-throughput extraction of a dataset from the field of medical imaging, is one of the most popular research topics today.
Also, AI is essential for the examination of a significant number of medical images, which uncovers sickness symptoms that would otherwise go undetected. As a result, it is projected that during the coming years, the market for AI in medical imaging will grow. Scientists have made great progress in the fight against COVID-19, and new research findings, like analytical studies and publications from academic and industrial researchers, are appearing every day. In the context of medical imaging investigations, an increasing number of researchers are using artificial intelligence (AI) to identify and anticipate diseases. Hence, image analysis, image segmentation of infected lung areas, and analytics for clinical evaluation form the backbone of AI-based COVID-19 diagnosis methods. These AI-based techniques have demonstrated excellent commercialization potential for AI in the field of medical imaging during the predicted timeframe.
Because of the rapid development of digital health, healthcare practitioners may now assist patients through cutting-edge treatment modalities. Doctors can more accurately identify and treat patients with the use of AI technology. Doctors, it has been noticed, are hesitant to use new technology. For example, doctors erroneously think AI will someday replace them in the medical industry. According to doctors and radiologists, since attributes like empathy and persuasion are seen as being human, technology cannot completely rule out the existence of a doctor. Another concern is that patients' excessive reliance on these technologies may cause them to reject necessary in-person therapies, straining long-term doctor-patient relationships.
Several doctors are concerned about the precision with which AI can identify patients' illnesses. It might be challenging to convince providers that AI-based solutions are cost-efficient, secure, and efficient options that give doctors convenience and improve patient care. Yet, healthcare practitioners are more receptive to the potential benefits of AI-based solutions and the range of industries they may be applied to. As a result, it's feasible that in the years to come, doctors and radiologists will be more open to AI-based healthcare technologies.
June 2021: FDA accepted AI's application for CINA-LVO, CINA-ICH, and neurovascular crises, according to a report from the Nuance AI marketplace. This is the largest and first gateway of its sort in the United States, providing a single point of entry to a broad range of AI diagnostic models within the radiology reporting platform.
June 2021: VUNO Inc., a South Korean AI business, announced a strategic partnership with Samsung Electronics for the incorporation of the AI-powered mobile digital X-ray system VUNO Med-Chest X-ray within the GM85. This partnership is projected to bring VUNO closer to the expansion of AI applications that are market-ready due to its access to the global market.
The US did not have specific regulations on the use of artificial intelligence (AI) in medical imaging. However, the Food and Drug Administration (FDA) has issued guidance on the development and validation of AI in medical devices.
The FDA issued a draft guidance in 2019 titled "Clinical Decision Support Software" to provide a framework for regulating AI-based software as a medical device. The guidance sets out the agency's approach to regulating software that analyzes medical images, including requirements for data integrity, clinical evaluation, and quality control.
The FDA has also established the Digital Health Center of Excellence to provide support and guidance to developers of digital health technologies, including AI-based medical imaging software. The center aims to promote innovation while ensuring patient safety and regulatory compliance. Overall, while there are no specific regulations on AI in medical imaging, the FDA's guidance provides a framework for developers to navigate regulatory requirements and ensure their products are safe and effective. It's important to note that the regulatory landscape is constantly evolving, and developers should stay up to date on any changes in regulations that may impact their products.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
188.8.131.52 Product Applications and Services
184.108.40.206 Recent Developments
220.127.116.11 Partnerships Ecosystem
18.104.22.168 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By AI Technology
When compared to CT scans, magnetic resonance imaging can produce pictures that are free of imperfections. Due to its efficiency in obtaining details and better-quality pictures of soft tissues, the MRI is frequently seen as a superior alternative to X-rays. Utilizing optical coherence tomography, three-dimensional interactions between the retina and membranes are made possible in order to control the vitreoretinal disease.
The market is dominated by the digital pathology segment, which can be linked to pathologists' rising productivity. A validation tool for image analytics is provided by digital pathology, helping pathologists process more slides in less time. This facilitates early illness identification and quicker therapy initiation. AI and digital pathology also assist doctors in making patient-centered decisions. The oncology market is also expected to grow in popularity as more individuals become aware of cancer and its increased incidence in the public. Personalized therapy is made possible by artificial intelligence algorithms that identify and comprehend the nature of malignancies. The second section focUses on AI-driven diagnostic imaging for the heart, brain, breast, and mouth.
By End Use
The market is dominated by the healthcare sector. This is becaUse hospitals are widely dispersed and accessible; hence, many patients like hospitals. The market for medical imaging AI is also anticipated to benefit from favorable reimbursement regulations. During the anticipated time, diagnostic centers are anticipated to grow in popularity. This may be attributable to elements including rising patient awareness and a desire for diagnostic procedures and tests, all of which are fueling the market's expansion. Due to its ease in providing high-quality medical facilities in remote places, particularly rural ones, the ambulatory category is expected to develop at a quicker CAGR throughout the projection period. The availability of qualified surgeons and a surplAustralia of the necessary equipment are contributing to the expansion of the hospital market. Government assistance in emerging nations is likely to boost hospital infrastructure and technologies throughout the forecast period, which is anticipated to caUse the hospital segment to see growth.
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses